Menu

Blog

Page 4910

Nov 30, 2021

Qualcomm is set to lose top brands like Apple, Google & Samsung

Posted by in categories: computing, mobile phones

According to reports, Samsung will increase the proportion of Exynos chips used in its own models in 2022 to reduce its dependence on Qualcomm chips. Samsung’s use of Exynos chips in its own models will increase by about 2–3 times next year. At the same time, Samsung has set a sales target of 300 million mobile phones next year.

Industry insiders pointed out that Samsung is vigorously supporting Exynos chips. On the one hand, it will increase the proportion of Exynos chips in its own models. On the other hand, it is open to partners. Recall that the company co-developed the Exynos 1,080 chip with Vivo which the latter used in the Vivo X60 series.

Nov 30, 2021

Amazon launches AWS RoboRunner to support robotics apps

Posted by in category: robotics/AI

Amazon’s new service, AWS IoT RoboRunner, is designed to orchestrate fleets of robots and provide a repository for robotics systems data.

Nov 30, 2021

Unpatched Unauthorized File Read Vulnerability Affects Microsoft Windows OS

Posted by in category: futurism

Details of an unpatched vulnerability in the Windows 10 has been disclosed that could allow an attacker to gain unauthorized access to the file system.

Nov 30, 2021

4 Android Banking Trojan Campaigns Targeted Over 300,000 Devices in 2021

Posted by in categories: finance, mobile phones

Four separate Android banking trojan Dropper campaigns that have affected over 300,000 devices in 2021 through the Google Play Store.

Nov 30, 2021

CleanMyMac X: Performance and Security Software for Macbook

Posted by in category: security

Has your Macbook’s performance dipped in the recent past? CleanMyMac has all the tools you need to take care of your Mac. Read on to learn more.

Nov 30, 2021

Italy’s Antitrust Regulator Fines Google and Apple for “Aggressive” Data Practices

Posted by in category: futurism

An Italian antitrust regulator fined Google and Apple for “aggressive” data practices.

Nov 30, 2021

AI-assisted device could soon replace traditional stethoscopes

Posted by in categories: biotech/medical, robotics/AI

Stethoscopes are among doctors’ most important instruments, yet there have not been any essential improvements to the device since the 1960s. Now, researchers at Aalto University have developed a device that analyzes a broad range of bodily functions and offers physicians a probable diagnosis as well as suggestions for appropriate further examinations. The researchers believe that the new device could eventually replace the stethoscope and enable quicker and more precise diagnoses.

A startup called Vital Signs is taking the device to the market. The researchers are currently testing the device in a clinical pilot trial. The intention is to launch the product to the most important European markets by the end of 2023.

“We have a well-functioning prototype, and the development path is clear,” says Alexis Kouros, the doctor leading the research team at Aalto.

Nov 30, 2021

What Happens During a Quantum Jump?

Posted by in category: quantum physics

PBS Member Stations rely on viewers like you. To support your local station, go to: http://to.pbs.org/DonateSPACE
↓ More info below ↓

Erratum: Figures in episode should be Minev et al. (2019), not Minney et al. (2009). Our apologies to the authors!

Continue reading “What Happens During a Quantum Jump?” »

Nov 29, 2021

How Omicron, the New Covid-19 Variant, Got Its Name

Posted by in category: biotech/medical

Markets plunged on Friday, hope of taming the coronavirus dimmed and a new term entered the pandemic lexicon: Omicron.

The Covid-19 variant that emerged in South Africa was named after the 15th letter of the Greek alphabet.

The naming system, announced by the World Health Organization in May, makes public communication about variants easier and less confusing, the agency and experts said.

Nov 29, 2021

Pfizer expects COVID-19 antiviral to work against omicron

Posted by in category: biotech/medical

Pfizer is confident its COVID-19 antiviral pill, Paxlovid, will be effective against the new omicron variant, the drugmaker’s CEO told CNBC Nov. 29.

The omicron strain, first detected in South Africa, contains 32 mutations in the spike protein, and while preliminary evidence suggests the strain may increase the risk of reinfection, it’s still uncertain how the variant may affect illness severity or the effectiveness of vaccines and treatments.

Albert Bourla, PhD, Pfizer’s CEO, told CNBC the company’s antiviral was created with the spike protein in mind and expects it will work against omicron.